Biocon Limited (NSE: BIOCON)
India
· Delayed Price · Currency is INR | Market Cap | 402.07B |
| Revenue (ttm) | 148.94B |
| Net Income (ttm) | 14.39B |
| Shares Out | 1.20B |
| EPS (ttm) | 12.00 |
| PE Ratio | 27.99 |
| Forward PE | 46.83 |
| Dividend | 0.50 (0.15%) |
| Ex-Dividend Date | Jul 5, 2024 |
| Volume | 2,888,574 |
| Open | 350.00 |
| Previous Close | 350.35 |
| Day's Range | 335.15 - 351.30 |
| 52-Week Range | 244.55 - 395.80 |
| Beta | 0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 29, 2025 |
About Biocon
Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psor... [Read more]
Financial Performance
In 2023, Biocon's revenue was 147.56 billion, an increase of 32.05% compared to the previous year's 111.74 billion. Earnings were 10.23 billion, an increase of 120.99%.
Financial StatementsNews
Stocks to watch, December 16: Biocon, Lupin, Bharat Forge, Radico Khaitan, Dixon Tech, and Aurobindo Pharma and more in focus today
Here are our stocks to watch today on Dec 16, 2024: Biocon, Lupin, Bharat Forge, Radico Khaitan, Dixon Tech, Aurobindo Pharma, PVR Inox, RITES, Godrej Agrovet, HBL Power, Borosil Renewables, JK Paper ...
Pharma stocks: Divi’s Lab (+0.82%), IPCA (+0.83%) rise; Biocon (-1.86%), Glaxo (-1.44%) decline
The pharma sector showed a mixed trend during intraday trading as of 11:25 AM, with select stocks gaining while others faced selling pressure. Key Performances: Gaining Stocks: IPCA Laboratories: Up 0...
Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27%
The Nifty Pharma index was trading 0.25% lower at 22,389.10 during today’s session, as losses in Cipla, Biocon, and Aurobindo Pharma weighed on the sector, despite gains in Abbott India and Ajanta Pha...
Biocon shares surge nearly 3% after FDA nod for Yesintek, a biosimilar to Stelara
Shares of Biocon surged by 2.7% to Rs 375 on Monday following the U.S. FDA’s approval for Yesintek, a biosimilar to Johnson & Johnson’s blockbuster arthritis drug, Stelara. This approval marks a signi...
Stocks to watch today: Maruti Suzuki, TVS Motor, Biocon, DLF, RVNL, RBL, Cipla, Home First, Cochin Shipyard in focus
The stock market is abuzz with updates across several companies today. Below are the highlights in the green and red zones: Maruti Suzuki: November sales saw a minor beat, driven by a strong performan...
Pharma stocks weekly roundup: Biocon leads with 9.08% gain, Torrent Pharma up 4.91%, Lupin dips 1.82%
The pharmaceutical sector experienced diverse movements during the week of November 25–29, 2024. Among the notable performers, Biocon Ltd led the gains with a significant surge of ₹30.35 (9.08%), clos...
Biocon shares surge over 3% after Bengaluru facilities get VAI Tag from USFDA
Biocon Ltd. saw its shares rise by more than 3% in early trading after the U.S. Food and Drug Administration (USFDA) issued a “Voluntary Action Indicated” (VAI) tag to the manufacturing facilities of ...
Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure
In today’s market action, key stocks to watch include Divi’s Laboratories, which reported better-than-expected results, and JSW Steel, which has been chosen as the preferred bidder for new coal blocks...
Access to healthcare will remain a priority for the US, says Biocon CEO
Peter Bains, Group CEO of Biocon, talks about how the India-based pharmaceutical company is placed ahead of a second Trump presidency, as well as the development of its weight-loss and anti-obesity dr...
Pharma Sector Stocks: Granules down 1.68%, Akums slips 1.29%, Zydus Life up 0.13%, Aurobindo Pharma gains 0.99% in early trade
Time Stamp: November 4, 2024, 9:41 AM Market Update: Pharma stocks opened with a mixed trend today, showing slight gains and losses among the major players. SPARC: Down by 1.81%, trading at ₹212.04 PP...
Stocks to watch today: L&T, Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon post Q2 results – Brokerage reports inside
Several leading companies, including Larsen & Toubro (L&T), Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon, announced their Q2 FY25 results yesterday. Here’s a look at their performance, ...
Biocon Q2 FY25 Results: Company posts net loss of Rs 16 crore, Revenue flat at Rs 3,623 crore
Biocon reported a net loss of ₹16 crore for the period, attributed to higher tax expenses resulting from a geographical shift in profits and minority interest.
Stocks to watch today as key Q2 FY24-25 results roll in: L&T, Tata Power, Dabur, PGHH, Biocon, Aditya Birla Capital and more
Today is set to be an active trading day with several prominent companies scheduled to release their Q2 FY24-25 earnings. Investors will be closely analyzing these results to gauge company performance...
HSBC on Biocon: Reduce call, sees 7.8% downside from current share price
HSBC has maintained its reduce rating on Biocon, lowering the share price target to ₹300, implying a 7.8% downside from the current market price (CMP). A positive court ruling positions Amgen well for...
Pharma Stocks Update: Check out how Cipla, Lupin, Abbott India, Divi’s Lab, Zydus Life, Dr Reddy’s Lab are performing today
JB Chem rises 1.91%, Biocon gains 0.87%, while Natco Pharma drops 2.65% and Gland Pharma slips 1.38% in today's trade.
Biocon’s subsidiary refinances USD 1.1 Billion long-term debt through USD bonds and new syndicated facility
Biocon Biologics Limited (BBL), a subsidiary of Biocon Limited, successfully refinanced its USD 1.1 billion (INR 93,468 million) long-term debt through the issuance of USD 800 million (INR 66,763 mill...
Stock Market 14 Feb, Today: Focus on new listings, 3 IPOs to track today
Today’s stock market highlights several companies experiencing key developments, with notable movements in IT, renewable energy, pharma, and finance sectors. Accenture’s positive revenue guidance has ...
Biocon Limited partners with Tabuk Pharmaceuticals
To commercialise its Glucagon-like peptide-1 (GLP -1) products in the Middle East region
Biocon and Tabuk Pharmaceuticals join forces to commercialize GLP-1 products in Middle East markets
Biocon Limited has recently informed exchanges that the company has signed a licensing and supply agreement with Tabuk Pharmaceutical Manufacturing Company (a fully-owned subsidiary of Astra Industria...
F&O ban update: ABFRL, IDEA enter ban; RBL Bank exits on Sept 24
In today’s stock market session, several changes were observed in the Futures and Options (F&O) ban list. New additions to the ban: ABFRL and IDEA have been placed under the F&O ban. These stocks have...
Stock market news: Aarti Industries, Biocon, GNFC, Granules India among stocks in F&O ban list on September 20
Several stocks remain in the Futures and Options (F&O) ban period as their open interest (OI) has crossed 95% of the market-wide position limits (MWPL). These stocks will remain in the ban until their...
LIC increases its stake in Biocon to 5.03%
The Life Insurance Corporation of India (LIC) has announced an increase in its equity shareholding in Biocon Ltd
Biocon Biologics set to raise $950 million through overseas bonds
Biocon Biologics is planning to raise $950 million by selling bonds overseas, according to reports of Economic Times. The fundraising will be handled by lenders including Standard Chartered Bank and H...
Who is Piyush Pratik, the IIT-graduate Apple product manager who spoke about Camera Control feature on iPhone 16 series
Apple introduced its iPhone 16 series at a launch event where Piyush Pratik highlighted the new Camera Control feature. An IIT Delhi alumnus and Stanford MBA graduate, Pratik has a notable career hist...
Biocon, ABRFL, Hindustan Copper among other stocks in F&O ban list on September 9
As of today, September 9, 2024, several stocks are under a trading ban in the futures and options (F&O) markets. This ban is enforced when the open interest on a stock reaches more than 95% of the mar...